Efstathios Karamanos1, Sophie Dream2, Anthony Falvo3, Nathan Schmoekel4, Aamir Siddiqui5. 1. Surgeon in the Division of Acute Care Surgery in the Department of Surgery at Henry Ford Hospital in Detroit, MI. ekarama1@hfhs.org. 2. Surgeon at Henry Ford Hospital in Detroit, MI. sdream1@hfhs.org. 3. Surgeon at Henry Ford Hospital in Detroit, MI. afalvo1@hfhs.org. 4. Surgeon in the Division of Acute Care Surgery at Henry Ford Hospital in Detroit, MI. nschmoeke2@hfhs.org. 5. Plastic and Reconstructive Surgeon at Henry Ford Hospital in Detroit, MI. asiddiq1@hfhs.org.
Abstract
CONTEXT: Use of epidural analgesia in patients undergoing elective abdominal wall reconstruction is common. OBJECTIVE: To assess the impact of epidural analgesia in patients undergoing abdominal wall reconstruction. DESIGN: All patients who underwent elective ventral hernia repair from 2005 to 2014 were retrospectively identified. Patients were divided into two groups by the postoperative use of epidural analgesics as an adjunct analgesic method. Preoperative comorbidities, American Society of Anesthesiologists status, operative findings, postoperative pain management, and venothromboembolic prophylaxis were extracted from the database. Logistic regressions were performed to assess the impact of epidural use. MAIN OUTCOME MEASURES: Severity of pain on postoperative days 1 and 2. RESULTS: During the study period, 4983 patients were identified. Of those, 237 patients (4.8%) had an epidural analgesic placed. After adjustment for differences between groups, use of epidural analgesia was associated with significantly lower rates of 30-day presentation to the Emergency Department (adjusted odds ratio [AOR] = 0.53, 95% confidence interval [CI] = 0.32-0.87, adjusted p = 0.01). Use of epidural analgesia resulted in higher odds of abscess development (AOR = 5.89, CI = 2.00-17.34, adjusted p < 0.01) and transfusion requirement (AOR = 2.92, CI = 1.34-6.40, adjusted p < 0.01). Use of epidural analgesia resulted in a significantly lower pain score on postoperative day 1 (3 vs 4, adjusted p < 0.01). CONCLUSION: Use of epidural analgesia in patients undergoing abdominal wall reconstruction may result in longer hospital stay and higher incidence of complications while having no measurable positive clinical impact on pain control.
CONTEXT: Use of epidural analgesia in patients undergoing elective abdominal wall reconstruction is common. OBJECTIVE: To assess the impact of epidural analgesia in patients undergoing abdominal wall reconstruction. DESIGN: All patients who underwent elective ventral hernia repair from 2005 to 2014 were retrospectively identified. Patients were divided into two groups by the postoperative use of epidural analgesics as an adjunct analgesic method. Preoperative comorbidities, American Society of Anesthesiologists status, operative findings, postoperative pain management, and venothromboembolic prophylaxis were extracted from the database. Logistic regressions were performed to assess the impact of epidural use. MAIN OUTCOME MEASURES: Severity of pain on postoperative days 1 and 2. RESULTS: During the study period, 4983 patients were identified. Of those, 237 patients (4.8%) had an epidural analgesic placed. After adjustment for differences between groups, use of epidural analgesia was associated with significantly lower rates of 30-day presentation to the Emergency Department (adjusted odds ratio [AOR] = 0.53, 95% confidence interval [CI] = 0.32-0.87, adjusted p = 0.01). Use of epidural analgesia resulted in higher odds of abscess development (AOR = 5.89, CI = 2.00-17.34, adjusted p < 0.01) and transfusion requirement (AOR = 2.92, CI = 1.34-6.40, adjusted p < 0.01). Use of epidural analgesia resulted in a significantly lower pain score on postoperative day 1 (3 vs 4, adjusted p < 0.01). CONCLUSION: Use of epidural analgesia in patients undergoing abdominal wall reconstruction may result in longer hospital stay and higher incidence of complications while having no measurable positive clinical impact on pain control.
Authors: John R A Rigg; Konrad Jamrozik; Paul S Myles; Brendan S Silbert; Phillip J Peyton; Richard W Parsons; Karen S Collins Journal: Lancet Date: 2002-04-13 Impact factor: 79.321
Authors: Michael B Ujiki; Jeremy Weinberger; Thomas K Varghese; Kenric M Murayama; Raymond J Joehl Journal: Am J Surg Date: 2004-11 Impact factor: 2.565
Authors: Jerome F O'Hara; Jacek B Cywinski; John E Tetzlaff; Meng Xu; Alan R Gurd; Jack T Andrish Journal: Paediatr Anaesth Date: 2004-12 Impact factor: 2.556
Authors: Siok S Ching; Abeezar I Sarela; Simon P L Dexter; Jeremy D Hayden; Michael J McMahon Journal: Surg Endosc Date: 2008-07-12 Impact factor: 4.584
Authors: Mark R Jones; Ethan Y Brovman; Amy E Wagenaar; Samuel P Ang; Edward E Whang; Alan D Kaye; Richard D Urman Journal: Psychopharmacol Bull Date: 2020-10-15